A phase 3 trial of CRLX101 in combination with Avastin in patients with 3rd and 4th line Renal cell carcinoma
Latest Information Update: 10 Aug 2015
At a glance
- Drugs Camptothecin (Primary) ; Bevacizumab
- Indications Renal cell carcinoma
- Focus Therapeutic Use
Most Recent Events
- 10 Aug 2015 New trial record